Advanced Solutions for Cell and Gene Therapy Material Management

As the field of Cell & Gene Therapy rapidly advances, there has been a corresponding growth in supply chain solutions to meet the precise requirements of this industry. The combination of complex manufacturing processes, high facility costs and stringent regulatory requirements puts strain on a therapy’s development. Cryoport Systems’ BioServices capabilities allow manufacturers to build and maintain a stronger supply chain.

This white paper discusses the growing demand for supply chain management solutions, capabilities that support manufacturers during their product development, and the network of compliance certifications and standards needed for managing cell and gene materials.

Read BioServices White Paper